Are you a growth company considering a UK public listing?
If so, you should consider AQSE as well as AIM and the Main Market. AQSE has a regime which is suited to smaller growth companies and is gaining traction with more institutional investors since its takeover by Aquis.
Our lawyers have an excellent track record supporting issuers and advisers on listings and equity fundraisings. We represent issuers, investment banks, nominated advisers, financial advisers, corporate advisers, investors and others on the entire range of transactions on the Main Market, AIM and AQSE as well as advising clients on Takeover Code transactions. We have approximately 70 UK listed issuer clients including 15 listed on Aquis.
We have outlined below the major transactions that our team have closed on Aquis since March 2020, which shows how other companies have used this market to further their growth ambitions.
We have outlined below the major transactions that our team have closed since March 2020 on this market. If you have any queries or would like further information on Aquis, please do not hesitate to get in touch.
Hill Dickinson client British Honey Company admitted to trading on the AQSE
Shares in BHC, the premium British Honey and Infused Spirits brand, were admitted to trading on the Aquis Stock Exchange Growth Market (AQSE)…read more.
Hill Dickinson advises Vulcan Industries Plc on its admission to the AQSE
Our corporate team has advised Vulcan Industries Plc on a placing and the company’s admission to trading on the Aquis Stock Exchange Growth Market (AQSE)…read more.
Hill Dickinson advises S-Ventures Plc on its admission to the AQSE Growth Market
Our corporate team has recently advised its client, S-Ventures Plc (S-Ventures), on the admission of its entire issued capital to the AQSE Growth Market, which is operated by Aquis Stock Exchange Limited….read more.
Hill Dickinson advises Sativa Group on takeover by Stillcanna Inc, the first public takeover of a UK company operating in the medical cannabis and CBD wellness sector
Corporate team has advised Sativa Group plc, the UK’s leading quoted CBD wellness and medicinal cannabis group, on the recommended share-for-share offer by Stillcanna Inc. The transaction represents the first public takeover by a Canadian-listed entity of a UK company operating in the medical cannabis sector…read more.
Hill Dickinson advises TruSpine Technologies on its admission to the AQSE
Our London corporate team has advised TruSpine Technologies plc (TruSpine) on an IPO fundraise and the company’s admission to trading on the Aquis Stock Exchange Growth Market (AQSE)…read more.
If you have any queries, please contact Jonathan Morris - partner in our Corporate team.